KCNJ2 Gene Short QT Syndrome Type 3 Genetic Test sale cost 4400 AED
MT-TF Gene MELAS syndrome Genetic Test sale cost 4400 AED MT-TF Gene MELAS syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CALM1 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 4 Genetic Test sale cost 4400 AED CALM1 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 4 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

KCNJ2 Gene Short QT Syndrome Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KCNJ2 Gene Short QT Syndrome Type 3 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the KCNJ2 gene, which are associated with Short QT Syndrome Type 3 (SQT3). This condition is a rare, inheritable cardiac anomaly characterized by an abnormally short QT interval on an electrocardiogram (ECG), which can lead to life-threatening arrhythmias and sudden cardiac death. The test plays a critical role in the early detection and management of the syndrome, enabling healthcare providers to implement preventive measures and appropriate treatments to mitigate risks associated with the condition. Priced at 4400 AED, this genetic test is a crucial tool for individuals with a family history of Short QT Syndrome or unexplained cardiac events, offering them an opportunity for informed medical decision-making and personalized healthcare planning.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNJ2 Gene Short QT syndrome type 3 Genetic Test

About the Test

The KCNJ2 Gene Short QT syndrome type 3 Genetic Test is offered by DNA Labs UAE. This test is used to diagnose Short QT syndrome type 3, a rare genetic disorder affecting the electrical system of the heart.

Test Components

  • Test Name: KCNJ2 Gene Short QT syndrome type 3 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for KCNJ2 Gene Short QT syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNJ2 Gene Short QT syndrome type 3 NGS Genetic DNA Test gene KCNJ2

Test Details

The KCNJ2 gene is responsible for producing a protein called Kir2.1, which regulates the electrical activity of the heart. Mutations in the KCNJ2 gene can lead to Short QT syndrome type 3 (SQT3), a rare genetic disorder characterized by abnormally short QT intervals on an electrocardiogram (ECG). This condition can result in episodes of rapid heartbeats and potentially life-threatening arrhythmias.

NGS (Next-Generation Sequencing) is a genetic testing method used to analyze multiple genes simultaneously, including the KCNJ2 gene. This allows for a comprehensive evaluation of the entire gene, enabling a more accurate diagnosis of Short QT syndrome type 3. Genetic testing for KCNJ2 gene mutations can confirm a diagnosis of Short QT syndrome type 3 and guide treatment decisions. It can also provide valuable information for family members who may be at risk of inheriting the condition.

It is important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor, who can provide appropriate counseling and interpretation of the results.

Test Name KCNJ2 Gene Short QT syndrome type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCNJ2 Gene Short QT syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNJ2 Gene Short QT syndrome type 3 NGS Genetic DNA Test gene KCNJ2
Test Details

The KCNJ2 gene is responsible for producing a protein called Kir2.1, which plays a crucial role in regulating the electrical activity of the heart. Mutations in the KCNJ2 gene can lead to a condition called Short QT syndrome type 3 (SQT3).

Short QT syndrome is a rare genetic disorder that affects the electrical system of the heart, resulting in abnormally short QT intervals on an electrocardiogram (ECG). This can lead to episodes of rapid heartbeats (ventricular tachycardia) and potentially life-threatening arrhythmias.

NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes, including the KCNJ2 gene, to identify any mutations or variations that may be present. NGS can provide a comprehensive evaluation of the entire gene, enabling a more accurate diagnosis of Short QT syndrome type 3.

Genetic testing for KCNJ2 gene mutations can help confirm a diagnosis of Short QT syndrome type 3 and guide treatment decisions. It can also provide valuable information for family members who may be at risk of inheriting the condition.

It is important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor, who can provide appropriate counseling and interpretation of the results.

SKU: TEST-3474 Category:

Related products